FARA

Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia

Retrieved on: 
Monday, February 12, 2024

“Friedreich’s ataxia patients treated with SKYCLARYS in the clinical trial experienced important and clinically meaningful improvements for their daily lives.

Key Points: 
  • “Friedreich’s ataxia patients treated with SKYCLARYS in the clinical trial experienced important and clinically meaningful improvements for their daily lives.
  • At the end of the 48-week study, patients who received SKYCLARYS had significantly improved modified Friedreich Ataxia Rating Scale (mFARS) scores relative to placebo.
  • Biogen is committed to working closely with all stakeholders to ensure that eligible European patients can have access to this treatment.
  • SKYCLARYS is also approved for use in the United States, and Biogen is engaging with regulatory authorities in other regions.

World's Top 5 Military Helicopter & Rotorcraft Manufacturers Annual Strategy Report - Airbus Helicopters, Bell, Boeing, Leonardo and Sikorsky - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 21, 2023

The "Annual Strategy Dossier - 2023 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Annual Strategy Dossier - 2023 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.
  • The iconic military helicopters developed during the Cold War era, including, Black Hawk, Chinook and Apache are still in production & active service even decades after they first made their mark and having proved their mettle across numerous battlefields and combat theatres over decades.
  • The FARA phase again has Bell and Sikorsky pitted against each other in an intense battle, especially, after the FLRAA phase went to Bell.
  • U.K.'s upcoming NMH program is going to be a key, near term growth avenue for the industry OEMs.

Rett Syndrome Research Trust Launches the Rett Syndrome Global Registry: A Pioneering Parent-Reported Platform Designed to Expedite the Development of Genetic Medicines

Retrieved on: 
Friday, November 10, 2023

TRUMBULL, Conn., Nov. 9, 2023 /PRNewswire-PRWeb/ -- The Rett Syndrome Research Trust (RSRT) is excited to announce the launch of the Rett Syndrome Global Registry, a fully-remote platform for parents to share their knowledge and experiences caring for loved ones with Rett syndrome. Inclusivity is a vital component of the Rett Global Registry. It is accessible to families regardless of geographic location, access to medical facilities, or socioeconomic status. Designed to advance the development of genetic medicines, the Rett Global Registry adheres to FDA guidance documents and complies with regulatory requirements. Biopharmaceutical companies pursuing therapeutic programs for Rett are urgently waiting to analyze data collected from the Rett Global Registry. Parents of children and adults with Rett syndrome are encouraged to register as soon as possible.

Key Points: 
  • Designed to advance the development of genetic medicines, the Rett Global Registry adheres to FDA guidance documents and complies with regulatory requirements.
  • Biopharmaceutical companies pursuing therapeutic programs for Rett are urgently waiting to analyze data collected from the Rett Global Registry.
  • TRUMBULL, Conn., Nov. 9, 2023 /PRNewswire-PRWeb/ -- The Rett Syndrome Research Trust (RSRT) is excited to announce the launch of the Rett Syndrome Global Registry, a fully-remote platform for parents to share their knowledge and experiences caring for loved ones with Rett syndrome.
  • Designed to advance the development of genetic medicines, the Rett Global Registry adheres to FDA guidance documents and complies with regulatory requirements.

GE Aerospace selected by Bell for V-280 Valor Future Long-Range Assault Aircraft

Retrieved on: 
Thursday, September 7, 2023

GE Aerospace today announced the selection by Bell Textron Inc., a Textron company, for work on the development of a Common Open Architecture Digital Backbone (COADB), Voice and Data Recorder , and the Health Awareness System (HAS) for the Bell V-280 Valor.

Key Points: 
  • GE Aerospace today announced the selection by Bell Textron Inc., a Textron company, for work on the development of a Common Open Architecture Digital Backbone (COADB), Voice and Data Recorder , and the Health Awareness System (HAS) for the Bell V-280 Valor.
  • Following the U.S. Army’s Future Long-Range Assault Aircraft (FLRAA) program contract award, the V-280 Valor will enable the U.S. Army and its allies to maintain battlefield superiority including transformational capabilities in speed, range, payload, and endurance.
  • The GE Aerospace systems will be part of an open, scalable, high-speed data infrastructure consistent with the U.S. Army’s Modular Open Systems Approach (MOSA) that enables rapid testing, verification, and fielding of mission-focused capabilities for future vertical lift programs.
  • Bell and GE Aerospace are incorporating these advanced capabilities on the Bell V-280 Valor and Bell 360 Invictus as part of the FLRAA and FARA programs, and working with the Army to set the standards for quicker, more affordable upgrades in capability as technologies and mission requirements evolve.

Congress Acts on Middle East Forum Investigation of Iranian Regime Mosques

Retrieved on: 
Thursday, August 10, 2023

Their letter stems directly from original investigative reporting by the Middle East Forum's media outlet, Focus on Western Islamism (FWI).

Key Points: 
  • Their letter stems directly from original investigative reporting by the Middle East Forum's media outlet, Focus on Western Islamism (FWI).
  • These institutions, the congress members state, are part of "a network of regime-sponsored mosques acting as agents for a foreign adversary.
  • MEF director Gregg Roman added: "Evidence suggests the Iranian terror regime has outposts managed by their own intelligence and security operations within American mosques.
  • The Middle East Forum promotes American interests in the region and protects Western civilization from Islamism.

Comparative SWOT & Strategy Focus of the World's Top 5 Military Helicopter & Rotorcraft Manufacturers 2023-2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 6, 2023

The "Comparative SWOT & Strategy Focus - 2023-2027 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Comparative SWOT & Strategy Focus - 2023-2027 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.
  • The European Union (EU), too, is looking at the future having launched the Next Generation Military Helicopter (NGMH) program, under PESCO, geared towards converting the next generation rotorcraft technologies into deployable solutions either as a retrofit over existing platforms or as a scratch-up platform in itself.
  • U.K.'s upcoming NMH program is going to be a key, near term growth avenue for the industry OEMs.
  • China's rapid military build-up & emergence as the regional belligerent power in the Asia-Pacific has other nations in the region spooked up setting off one of the biggest arms race in the APAC.

World's Top 5 Military Helicopter & Rotorcraft Manufacturers Competitive Landscape Report 2023-2027: Key Areas for Making Potential Strategic Changes, Adjustments & Realignment

Retrieved on: 
Wednesday, July 5, 2023

DUBLIN, July 4, 2023 /PRNewswire/ -- The "Comparative SWOT & Strategy Focus - 2023-2027 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 4, 2023 /PRNewswire/ -- The "Comparative SWOT & Strategy Focus - 2023-2027 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.
  • The iconic military helicopters developed during the Cold War era, including, Black Hawk, Chinook and Apache are still in production & active service even decades after they first made their mark and having proved their mettle across numerous battlefields and combat theatres over decades.
  • U.K.'s upcoming NMH program is going to be a key, near term growth avenue for the industry OEMs.
  • China's rapid military build-up & emergence as the regional belligerent power in the Asia-Pacific has other nations in the region spooked up setting off one of the biggest arms race in the APAC.

World Military Helicopter & Rotorcraft Manufacturer Strategy Dossier Report 2023: Comprehensive Analysis of Strategies & Plans for the Industry OEMs

Retrieved on: 
Monday, July 3, 2023

DUBLIN, July 3, 2023 /PRNewswire/ -- The "Annual Strategy Dossier - 2023 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 3, 2023 /PRNewswire/ -- The "Annual Strategy Dossier - 2023 - World's Top 5 Military Helicopter & Rotorcraft Manufacturers - Airbus Helicopters, Bell, Boeing, Leonardo, Sikorsky" report has been added to ResearchAndMarkets.com's offering.
  • The report provides insights into the key strategies & plans being formulated by the World's Top 5 Military Helicopter manufacturers & inputs to be incorporated into the broader strategic planning & decision making processes with focus on the overarching strategy focus across industry OEMs, analysis of key strategies & plans being formulated and a comprehensive SWOT analysis on them.
  • U.K.'s upcoming NMH program is going to be a key, near term growth avenue for the industry OEMs.
  • The report will be especially useful for:
    Top Management of Industry OEMs, Players across Industry Value Chain & Other Companies

North America and Europe Electric Bus Connected Infrastructure Market Report 2023-2027 with Key Profiles of 22 Aftermarket ITS Solution and 14 EV Charging Hardware Vendors - ResearchAndMarkets.com

Retrieved on: 
Monday, July 3, 2023

The "Connected Infrastructure for Electric Buses in North America and Europe - Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Connected Infrastructure for Electric Buses in North America and Europe - Market Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • This strategic research report covers the latest trends and developments on the intelligent transportation system and charging station market for electric buses in public transport.
  • The analyst at the same time estimates that the charging station market value for electric buses in the two regions was €160.7 million in 2022.
  • Profiles of 22 aftermarket ITS solution and 14 EV charging hardware vendors.

Vesigen Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy

Retrieved on: 
Tuesday, March 14, 2023

Vesigen will evaluate its proprietary technology to deliver CRISPR-Cas genome editing complexes as a non-viral disease-modifying strategy for patients diagnosed with the neurodegenerative disease Friedreich's Ataxia (FA).

Key Points: 
  • Vesigen will evaluate its proprietary technology to deliver CRISPR-Cas genome editing complexes as a non-viral disease-modifying strategy for patients diagnosed with the neurodegenerative disease Friedreich's Ataxia (FA).
  • The FARA Grant Program funds competitive grants across the spectrum from basic research through drug development and clinical research programs.
  • “The work being done by Vesigen Therapeutics has the potential to be transformative for FA patients,” says Jennifer Farmer, CEO of FARA.
  • “We are grateful for Dr. Nabhan and his team for their work on this targeted genome editing strategy.”
    This is the first grant in neurological disorders received by Vesigen Therapeutics.